Balyasny Asset Management
MTNB icon

Balyasny Asset Management’s Matinas BioPharma MTNB Stock Holding History

Balyasny Asset Management’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,982
Closed -$63K – 2585
2022
Q3 		$63K Buy
+1,982
New +$63K ﹤0.01% 1965